サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：不妊症診断と治療市場レポート：2030年までの動向、予測、競合分析
市場調査レポート
商品コード
1356790

不妊症診断と治療市場レポート：2030年までの動向、予測、競合分析

Infertility Diagnosis and Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

不妊症診断と治療市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

不妊症診断・治療の動向と予測

世界の不妊診断・治療市場は、2024年から2030年までのCAGRが7.9％で、2030年までに推定29億米ドルに達すると予測されます。この市場の主な促進要因は、出生率の低下、様々な不妊治療オプションの利用可能性の増加、世界中の不妊治療センター数の増加です。世界の不妊診断・治療市場の将来は、男性不妊治療市場と女性不妊治療市場にビジネスチャンスがあり、有望視されています。

不妊診断・治療市場の洞察

  • Lucintelは、女性不妊症診断が予測期間中に高い成長を遂げると予測しています。
  • 女性不妊治療は引き続き最大セグメントです。
  • 北米は、ライフスタイルの変化と高齢者人口の増加により、予測期間中も最大セグメントであり続ける。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の不妊症の診断および治療市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の不妊診断および治療市場の動向（2018-2023）および予測（2024-2030）
  • 診断別の世界の不妊診断および治療市場
    • 男性不妊症の診断
    • 女性不妊症の診断
  • 治療別の世界の不妊症診断および治療市場
    • 男性不妊治療
    • 女性の不妊治療
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の不妊症の診断および治療市場
  • 北米の不妊症診断および治療市場
  • 欧州の不妊症診断および治療市場
  • アジア太平洋の不妊症の診断と治療市場
  • その他地域不妊診断・治療市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 診断別の世界の不妊症診断および治療市場の成長機会
    • 治療別の世界の不妊診断および治療市場の成長機会
    • 地域別の世界の不妊診断および治療市場の成長機会
  • 世界の不妊診断および治療市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の不妊診断・治療市場の能力拡大
    • 世界の不妊症の診断および治療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Bayer AG
  • Bristol-Myers Squibb
  • Church & Dwight
  • Cook Medical
  • Coopersurgical
  • Eli Lilly
  • EMD Serono
  • Endo Pharmaceuticals
  • Ferring Pharmaceuticals
  • Genea
目次

Infertility Diagnosis and Treatment Trends and Forecast

The future of the global infertility diagnosis and treatment market looks promising with opportunities in the male infertility treatment and female infertility treatment markets. The global infertility diagnosis and treatment market is expected to reach an estimated $2.9 billion by 2030 with a CAGR of 7.9% from 2024 to 2030. The major drivers for this market are declining fertility rate, increasing availability of various fertility treatment options, and rising number of fertility centers across the globe.

A more than 150-page report is developed to help in your business decisions.

Infertility Diagnosis and Treatment by Segment

The study includes a forecast for the global infertility diagnosis and treatment by diagnosis, treatment, and region.

Infertility Diagnosis and Treatment Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Male Infertility Diagnosis
  • Female Infertility Diagnosis

Infertility Diagnosis and Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Male Infertility Treatment
  • Female Infertility Treatment
  • Others

Infertility Diagnosis and Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Infertility Diagnosis and Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies infertility diagnosis and treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the infertility diagnosis and treatment companies profiled in this report include-

  • Bayer AG
  • Bristol-Myers Squibb
  • Church & Dwight
  • Cook Medical
  • Coopersurgical
  • Eli Lilly
  • EMD Serono
  • Endo Pharmaceuticals
  • Ferring Pharmaceuticals
  • Genea

Infertility Diagnosis and Treatment Market Insights

  • Lucintel forecasts that female infertility diagnosis is expected to witness higher growth over the forecast period.
  • Female infertility treatment will remain the largest segment.
  • North America will remain the largest segment over the forecast period due to the changing lifestyle and growing geriatric population.

Features of the Global Infertility Diagnosis and Treatment Market

  • Market Size Estimates: Infertility diagnosis and treatment market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Infertility diagnosis and treatment market size by diagnosis, treatment, and region. in terms of value ($B).
  • Regional Analysis: Infertility diagnosis and treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different diagnosis, treatments, and region.s for the infertility diagnosis and treatment market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the infertility diagnosis and treatment market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the infertility diagnosis and treatment market size?

Answer: The global infertility diagnosis and treatment market is expected to reach an estimated $2.9 billion by 2030.

Q.2. What is the growth forecast for infertility diagnosis and treatment market?

Answer: The global infertility diagnosis and treatment market is expected to grow with a CAGR of 7.9% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the infertility diagnosis and treatment market?

Answer: The major drivers for this market are declining fertility rate, increasing availability of various fertility treatment options, and rising number of fertility centers across the globe.

Q.4. What are the major segments for infertility diagnosis and treatment market?

Answer: The future of the global infertility diagnosis and treatment market looks promising with opportunities in the male infertility treatment and female infertility treatment markets.

Q.5. Who are the key infertility diagnosis and treatment market companies?

Answer: Some of the key infertility diagnosis and treatment companies are as follows:

  • Bayer AG
  • Bristol-Myers Squibb
  • Church & Dwight
  • Cook Medical
  • Coopersurgical
  • Eli Lilly
  • EMD Serono
  • Endo Pharmaceuticals
  • Ferring Pharmaceuticals
  • Genea

Q.6. Which infertility diagnosis and treatment market segment will be the largest in future?

Answer: Lucintel forecasts that female infertility diagnosis is expected to witness higher growth over the forecast period.

Q.7. In infertility diagnosis and treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to the changing lifestyle and growing geriatric population.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the infertility diagnosis and treatment market by diagnosis (male infertility diagnosis and female infertility diagnosis), treatment (male infertility treatment, female infertility treatment, and Others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Infertility Diagnosis and Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Infertility Diagnosis and Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Infertility Diagnosis and Treatment Market by Diagnosis
    • 3.3.1: Male Infertility Diagnosis
    • 3.3.2: Female Infertility Diagnosis
  • 3.4: Global Infertility Diagnosis and Treatment Market by Treatment
    • 3.4.1: Male Infertility Treatment
    • 3.4.2: Female Infertility Treatment
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Infertility Diagnosis and Treatment Market by Region
  • 4.2: North American Infertility Diagnosis and Treatment Market
    • 4.2.2: North American Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others
  • 4.3: European Infertility Diagnosis and Treatment Market
    • 4.3.1: European Infertility Diagnosis and Treatment Market by Diagnosis: Male Infertility Diagnosis and Female Infertility Diagnosis
    • 4.3.2: European Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others
  • 4.4: APAC Infertility Diagnosis and Treatment Market
    • 4.4.1: APAC Infertility Diagnosis and Treatment Market by Diagnosis: Male Infertility Diagnosis and Female Infertility Diagnosis
    • 4.4.2: APAC Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others
  • 4.5: ROW Infertility Diagnosis and Treatment Market
    • 4.5.1: ROW Infertility Diagnosis and Treatment Market by Diagnosis: Male Infertility Diagnosis and Female Infertility Diagnosis
    • 4.5.2: ROW Infertility Diagnosis and Treatment Market by Treatment: Male Infertility Treatment, Female Infertility Treatment, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Infertility Diagnosis and Treatment Market by Diagnosis
    • 6.1.2: Growth Opportunities for the Global Infertility Diagnosis and Treatment Market by Treatment
    • 6.1.3: Growth Opportunities for the Global Infertility Diagnosis and Treatment Market by Region
  • 6.2: Emerging Trends in the Global Infertility Diagnosis and Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Infertility Diagnosis and Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Infertility Diagnosis and Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bayer AG
  • 7.2: Bristol-Myers Squibb
  • 7.3: Church & Dwight
  • 7.4: Cook Medical
  • 7.5: Coopersurgical
  • 7.6: Eli Lilly
  • 7.7: EMD Serono
  • 7.8: Endo Pharmaceuticals
  • 7.9: Ferring Pharmaceuticals
  • 7.10: Genea